TDX/TDXFLX METHOTREXATE II 7A12-60

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2009-09-29 for TDX/TDXFLX METHOTREXATE II 7A12-60 manufactured by Abbott Diagnostics Int'l, Ltd.

Event Text Entries

[1122606] Revision surgery - pt was experiencing pain with the tibia. Surgeon decided to re-cut the tibia.
Patient Sequence No: 1, Text Type: D, B5


[1179477] The customer states that an order for the measurement of methotrexate was received by the lab for testing with the tdxflx methotrexate ii assay. The laboratory technician tested the sample for amikacin instead and reported a result out of the lab of <0. 02 umol/l. A second sample was drawn and a methotrexate level was ordered but the same technician tested the sample for amikacin and reported a result of <0. 02 umol/l out of the lab. The hospital pharmacist questioned these results because the patient was taking methotrexate. The patient received an overdose of methotrexate as a result with subsequent drugs given to the patient as a rescue treatment. The patient recovered. The two samples were then retested with the methotrexate ii assay with the first sample generating a methotrexate result of 14. 51 umol/l and the second sample generating a methotrexate result of 7. 38 umol/l. The customer stated that this was an error on the part of the technician and not an instrument error. The customer reported no other cases of incorrect assays being run. There is no other impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


[8304996] Analytical testing is not required for this evaluation, as a review of quality data will be sufficient to determine whether a product malfunction exists. Complaint activity was reviewed and identified no adverse trends in association with the issue currently under evaluation. No other complaints have been documented for running the incorrect assay, for reporting out patient results when having run the incorrect assay or for a patient receiving a treatment based off of incorrect results. A risk evaluation was completed by the customer site to evaluate the technician error. Based on the results of this investigation, the tdx/tdxflx methotrexate ii assay is performing as intended and no product malfunction was identified. No further investigation is required. This is a final report.
Patient Sequence No: 1, Text Type: N, H10


[8369450] This is an initial report. An investigation is in process. A final report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2623532-2009-00090
MDR Report Key1486195
Report Source05
Date Received2009-09-29
Date of Report2009-09-28
Date of Event2009-09-01
Date Mfgr Received2009-11-13
Date Added to Maude2009-11-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street200 ABBOTT PARK ROAD DEPT. 09B9, AP50
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT DIAGNOSTICS INT'L, LTD
Manufacturer StreetKM 58.0 CARRETERA 2 CRUCE DAVILA
Manufacturer CityBARCELONETA PR 00617
Manufacturer Postal Code00617
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTDX/TDXFLX METHOTREXATE II
Generic NameFOR THE MEASUREMENT OF METHOTREXATE IN HUMAN SERUM OR PLASMA
Product CodeLAO
Date Received2009-09-29
Catalog Number7A12-60
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT DIAGNOSTICS INT'L, LTD
Manufacturer AddressKM 58.0 CARRETERA 2 CRUCE DAVILA BARCELONETA PR 00617 00617


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2009-09-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.